Quarry LP’s Pacific Biosciences PACB Stock Holding History

Quarry LP’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-106,985	Closed	-$401K	–	2024
2024 Q1	$401K	Buy	+106,985	New	+$626K	0.08%	158

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quarry LP's PACB Position: Q2 2024 in Review

Quarry LP sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 106,985 shares — an estimated $401K sold.

Quarry LP first reported a position in PACB in Q1 2024 and held it in 1 quarter. The position peaked at $401K in Q1 2024. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

Quarry LP reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
Quarry LP sold 106,985 Pacific Biosciences shares in Q2 2024, an estimated $401K.
Quarry LP first reported a position in Pacific Biosciences in Q1 2024 and held it in 1 quarter.
Quarry LP's Pacific Biosciences position peaked at $401K in Q1 2024.
228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Quarry LP's 13F filing for Q2 2024, filed 14 Aug 2024.